Pity BI is already in the market with first mover advantage.
Doesn't matter what the contract says, if you don't sell any of your product because the competition got there first you don't get any of the commissions, royalties or any other cut.
And what's ACL doing about? They are waiting.
And why?
Because they decided to abdicate control of the product to a third party.
I'll wait for the buyout. If they adopt this strategy with the first drug they will adopt with every drug thereafter. Thus with such logic they are better off just to sell off the actual goose.
- Forums
- ASX - By Stock
- TSN
- close to earnings - can you smell it
close to earnings - can you smell it, page-27
-
- There are more pages in this discussion • 12 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add TSN (ASX) to my watchlist
(20min delay)
|
|||||
Last
1.0¢ |
Change
0.000(0.00%) |
Mkt cap ! $1.409M |
Open | High | Low | Value | Volume |
0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Featured News
TSN (ASX) Chart |
Day chart unavailable
The Watchlist
1CG
ONE CLICK GROUP LIMITED
Mark Waller, MD
Mark Waller
MD
Previous Video
Next Video
SPONSORED BY The Market Online